Open Society Voices

Newsletter Signup

Sign up to receive updates from the Open Society Foundations.

Students at a school table

Inclusive Education Reform Presents a Litmus Test for the Czech Republic

November 13, 2017Ostalinda Maya Ovalle, Štěpán Drahokoupil
Women walking along a street

Is Judicial Independence Finally Coming to Kyrgyzstan?

November 16, 2017Shamil Ibragimov, Joshua Russell
People inside a living room

After the Storm: Building a Better Houston

November 3, 2017John Henneberger

Open Society Voices

Kyrgyzstan’s Long Fight for Generic Drugs Is Finally Paying Off

February 17, 2016 | Aibek Mukambetov

With more affordable medicines, pervasive illnesses like hepatitis C can be treated more widely.

Hope for Improving Health Outcomes for Vulnerable Populations

February 9, 2016 | Kellen Russionello

A new program in California could vastly improve both health and criminal justice outcomes for the state’s most vulnerable populations.

For Funders, a Responsible Exit Is an Elusive Ideal

February 8, 2016 | Jonathan Cohen

How do foundations decide when a grantee can survive without them?

Women Speak Up Against an Archaic Abortion Law in Northern Ireland

January 27, 2016 | Kellie O’Dowd

Why is it still illegal to take a pill the World Health Organization calls an essential medicine?

To Change Drug Policy, First Change the Way You Measure It

January 21, 2016 | Dan Werb

Many governments are using the wrong metrics to evaluate their approach to drugs.

The Many Consequences of Violence Against Sex Workers

December 17, 2015 | Julia Lukomnik

Across Eastern Europe and Central Asia, a number of innovative programs are helping to counter the threats that sex workers face on a regular basis.

A Chance to Get Drug Policy Right

December 17, 2015 | Daniel Wolfe, Kasia Malinowska

In 1998, the world’s leaders hashed out a plan to create “a drug-free world.” In April, they’ll come together again—and search for a smarter way forward.

A New Look Behind the Pricing of a $1,000 Pill

December 7, 2015 | Azzi Momenghalibaf

A U.S. Senate investigation concludes that a blockbuster hepatitis C drug was priced to drive profits, not innovation. But that’s just the tip of the iceberg.

“Scared Straight” Anti-Drug Programs Aren’t Scaring Kids at All

November 25, 2015 | Joanne Csete

A new report suggests that fear-based abstinence programs like D.A.R.E. might actually increase drug use among youth.

The Grim Numbers and Human Cost of Violence against Trans People

November 20, 2015 | Carla LaGata/Carsten Balzer, Boglarka Fedorko

This year, 271 murdered trans and gender-diverse people will be added to the list of those honored on Transgender Day of Remembrance.

Pages